{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:47:38Z","timestamp":1753890458724,"version":"3.41.2"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Sigmoid colon cancer with spinal metastases is rare in distant metastasis. In addition, the prognosis of colon cancer patients with spinal metastases is extremely poor. In order to find effective therapeutic agents, we need to know the biological characteristics of such patients from related models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We collected sigmoid colon cancer tissue from a young female subject who was diagnosed with sigmoid colon cancer with multiple spinal metastases. We successfully established a sigmoid colon cancer organoid using this tissue and investigated drug screening in the patient. HE staining, immunohistochemistry, and DNA sequencing were utilized to compare the biological characteristics between the original tumor and the organoid. Furthermore, we investigated the drug screening of the sigmoid colon cancer organoid <jats:italic>in vitro<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A colon cancer organoid from sigmoid colon cancer with spinal metastases was successfully established. The organoid culture maintained the morphological features, histological features, and genomic landscape of the corresponding sigmoid colon cancer cells. Moreover, we performed drug screening tests to evaluate the effects of chemotherapeutic drugs and targeted drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The sigmoid colon cancer organoid with spinal metastases was a favorable preclinical model to explore the clinicopathologic characteristics of colon cancer patients with spinal metastases.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcell.2024.1510264","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T06:47:52Z","timestamp":1735886872000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment and characterization of a sigmoid colon cancer organoid with spinal metastasis"],"prefix":"10.3389","volume":"12","author":[{"given":"Jingyao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangsen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-1-0716-2293-3_7","article-title":"FACETS: fraction and allele-specific copy number estimates from tumor sequencing","volume":"2493","author":"Arora","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00268-015-3296-x","article-title":"The characteristics of bone metastasis in patients with colorectal cancer: a long-term report from a single institution","volume":"40","author":"Baek","year":"2016","journal-title":"World J. Surg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41556-019-0360-z","article-title":"Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening","volume":"21","author":"Boretto","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s13059-014-0454-7","article-title":"Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions","volume":"15","author":"Brannon","year":"2014","journal-title":"Genome Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41467-020-15155-6","article-title":"An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity","volume":"11","author":"Calandrini","year":"2020","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3892\/ijo.2019.4806","article-title":"Establishment and characterization of a novel cell line (cc-006cpm8) of moderately\/poorly differentiated colorectal adenocarcinoma derived from a primary tumor of a patient","volume":"55","author":"Chu","year":"2019","journal-title":"Int. J. Oncol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl9283","article-title":"Substitution mutational signatures in whole-genome-sequenced cancers in the UK population","volume":"376","author":"Degasperi","year":"2022","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2172-11-19","article-title":"Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients","volume":"11","author":"Deschoolmeester","year":"2010","journal-title":"BMC Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/CAD.0000000000000093","article-title":"Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel--a review","volume":"25","author":"de Weger","year":"2014","journal-title":"Anticancer Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"26580","DOI":"10.1073\/pnas.1911273116","article-title":"Pancreatic cancer organoids recapitulate disease and allow personalized drug screening","volume":"116","author":"Driehuis","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/14656566.2019.1574754","article-title":"Zoledronic acid for the treatment of prostate cancer","volume":"20","author":"Finianos","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10654-008-9256-0","article-title":"Bone mass density, subsequent risk of colon cancer and survival in postmenopausal women","volume":"23","author":"Ganry","year":"2008","journal-title":"Eur. J. Epidemiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-017-0578-1","article-title":"Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials","volume":"36","author":"Gdowski","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1002\/ijc.32775","article-title":"High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment","volume":"146","author":"Ge","year":"2020","journal-title":"Int. J. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ctrv.2011.09.003","article-title":"Direct and indirect anticancer activity of bisphosphonates: a brief review of published literature","volume":"38","author":"Gnant","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejca.2017.07.019","article-title":"High-depth sequencing of paired primary and metastatic tumours: implications for personalised medicine","volume":"84","author":"Grellety","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13046-023-02683-4","article-title":"Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study","volume":"42","author":"Jensen","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4143\/crt.2017.307","article-title":"The generation and application of patient-derived xenograft model for cancer research","volume":"50","author":"Jung","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"B23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/DCR.0000000000001071","article-title":"Characteristics and prognostic factors of bone metastasis in patients with colorectal cancer","volume":"61","author":"Kawamura","year":"2018","journal-title":"Dis. Colon Rectum"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1038\/s41588-024-01914-4","article-title":"Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity","volume":"56","author":"Khaliq","year":"2024","journal-title":"Nat. Genet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s11605-019-04308-8","article-title":"Colorectal cancer metastases to brain or bone and the relationship to primary tumor location: a population-based study","volume":"24","author":"Lei","year":"2019","journal-title":"J. Gastrointest. Surg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nrclinonc.2016.195","article-title":"RECIST - learning from the past to build the future","volume":"14","author":"Litiere","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12885-019-5379-9","article-title":"Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal patterns of selection in cancer and somatic tissues","volume":"171","author":"Martincorena","year":"2017","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1159\/000365001","article-title":"A report of disseminated carcinomatosis of the bone marrow originating from transverse colon cancer successfully treated with chemotherapy using XELOX plus bevacizumab","volume":"7","author":"Naito","year":"2014","journal-title":"Case Rep. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.cell.2018.07.027","article-title":"Divergent routes toward Wnt and R-spondin niche independency during human gastric carcinogenesis","volume":"174","author":"Nanki","year":"2018","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-024-07769-3","article-title":"Prognostic genome and transcriptome signatures in colorectal cancers","volume":"633","author":"Nunes","year":"2024","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/13543776.2016.1111872","article-title":"Taxane anticancer agents: a patent perspective","volume":"26","author":"Ojima","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"B36","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","article-title":"Personalized in vitro and in vivo cancer models to guide precision medicine","volume":"7","author":"Pauli","year":"2017","journal-title":"Cancer Discov."},{"key":"B37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e100300","DOI":"10.15252\/embj.2018100300","article-title":"Long-term expanding human airway organoids for disease modeling","volume":"38","author":"Sachs","year":"2019","journal-title":"EMBO J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2967\/jnumed.117.192534","article-title":"Functional optical imaging of primary human tumor organoids: development of a personalized drug screen","volume":"58","author":"Walsh","year":"2017","journal-title":"J. Nucl. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","article-title":"Tumor organoids as a pre-clinical cancer model for drug discovery","volume":"24","author":"Weeber","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","article-title":"A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1089\/dna.2020.6457","article-title":"ASPM is a novel candidate gene associated with colorectal cancer cell growth","volume":"40","author":"Yang","year":"2021","journal-title":"DNA Cell Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10495-023-01933-2","article-title":"Unveiling the hidden role of disulfidptosis in kidney renal clear cell carcinoma: a prognostic signature for personalized treatment","volume":"29","author":"Ye","year":"2024","journal-title":"Apoptosis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4238\/gmr.15028643","article-title":"Models of logistic regression analysis, support vector machine, and back-propagation neural network based on serum tumor markers in colorectal cancer diagnosis","volume":"15","author":"Zhang","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1258951","DOI":"10.3389\/fonc.2023.1258951","article-title":"AHNAKs roles in physiology and malignant tumors","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Oncol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jbo.2017.10.003","article-title":"Retrospective study of predictors of bone metastasis in colorectal cancer patients","volume":"9","author":"Zihua Zhu","year":"2017","journal-title":"J. Bone Oncol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2024.1510264\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T06:47:55Z","timestamp":1735886875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2024.1510264\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":49,"alternative-id":["10.3389\/fcell.2024.1510264"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2024.1510264","relation":{},"ISSN":["2296-634X"],"issn-type":[{"type":"electronic","value":"2296-634X"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"article-number":"1510264"}}